Among early onset breast cancer patients who were diagnosed before 35 years of age, prevalence of germline variants in BRCA1, BRCA2, and other genes was 9.8%, 17.1%, and 4.9%, respectively (Supplementary Fig. 3b). This evidence concerns the gene BRCA2 and breast cancer.